Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Next-Generation Sequencing of Plasma Cell-Free DNA for Treatment Monitoring in Advanced Head and Neck Cancer Patients.

Clinical laboratory - 1 Jul 2020

Bai Jing, Zhang Shurong, Li Xinyu, Zhang Yong, Liu Xiangyi

Abstract excerpt

BACKGROUND: Liquid biopsy, especially circulating tumor DNA (ctDNA), has been reported to provide information on tumor genetic features and possible disseminated disease in many kinds of solid tumors. In this pilot study, we investigated the utilization of ctDNA for monitoring treatment response and progression of the disease in patients with head and neck cancers (HNC) by next-generation sequencing (NGS)....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell-Free Nucleic Acids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to High-Throughput Nucleotide Sequencing

Share to Lung Neoplasms

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Pilot Projects

Source

Identifiers

PMID: 32658437
DOI: 10.7754/Clin.Lab.2019.191150

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Next-Generation Sequencing of Plasma Cell-Free DNA for Treatment Monitoring in Advanced Head and Neck Cancer Patients.PMID 32658437Read ↗

Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).Semantic proximity Read ↗

Circulating tumour DNA alterations as biomarkers for head and neck cancer: a systematic review.Semantic proximity Read ↗

Does circulating tumor DNA apply as a reliable biomarker for the diagnosis and prognosis of head and neck squamous cell carcinoma?Semantic proximity Read ↗

Personalized circulating tumor DNA dynamics predict survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancerSemantic proximity Read ↗

Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinomaSemantic proximity Read ↗

Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay.Semantic proximity Read ↗

Tumour informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post-treatmentSemantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.Semantic proximity Read ↗

Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types.Semantic proximity Read ↗

Circulating Cell-Free DNA—Diagnostic and Prognostic Applications in Personalized Cancer TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.